SCHEMBL4455965

SCHEMBL4455965

CCNC(=S)NN=Cc1ccc(-c2cccc(Cl)c2)o1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.75
HPGD P15428 5/20 0.75
LMNA P02545 4/20 0.75
ALOX12 P18054 2/20 0.75
PHGDH O43175 5/20 0.67
MAPT P10636 8/20 0.64
KDM4E B2RXH2 7/20 0.57
GAA P10253 3/20 0.57
CYP1A2 P05177 2/20 0.57
CYP2C19 P33261 2/20 0.57
CYP2C9 P11712 1/20 0.57
NPC1 O15118 3/20 0.55
RAB9A P51151 3/20 0.55
PKM P14618 2/20 0.55
MAPK1 P28482 1/20 0.55
POLB P06746 1/20 0.55
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
NPSR1 Q6W5P4 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13611595 1.00 ALDH1A1 (0.75) ALDH1A1HPGDLMNAALOX12PHGDH
SCHEMBL13611475 0.87 MAPT (0.71) ALDH1A1HPGDLMNAALOX12MAPT
SCHEMBL21292670 0.86 PHGDH (0.80) ALDH1A1HPGDLMNAALOX12PHGDH
SCHEMBL21292759 0.86 ALDH1A1 (1.00) ALDH1A1HPGDLMNAALOX12PHGDH
SCHEMBL4455860 0.85 PHGDH (0.77) ALDH1A1HPGDLMNAALOX12PHGDH
SCHEMBL13886982 0.85 PHGDH (0.77) ALDH1A1HPGDLMNAALOX12PHGDH
SCHEMBL4343479 0.84 ALDH1A1 (0.71) ALDH1A1HPGDLMNAALOX12PHGDH
SCHEMBL13611582 0.84 ALDH1A1 (0.71) ALDH1A1HPGDLMNAALOX12PHGDH
SCHEMBL12879871 0.83 PHGDH (0.56) ALDH1A1HPGDLMNAALOX12PHGDH
SCHEMBL4328162 0.82 MAPT (0.79) ALDH1A1HPGDLMNAALOX12MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7521062-B2 Thiosemicarbazones as anti-virals and immunopotentiators NOVARTIS VACCINES & DIAGNOSTICS, INC. (US) 2009-04-21 US disclosed